PLAY PODCASTS
The HBV Gray Zone: Patient and Physician Sharing Session #5
Episode 70

The HBV Gray Zone: Patient and Physician Sharing Session #5

In episode 5 of an ongoing series of sharing sessions between a physician and patient, Anna Christina L. dela Cruz, MD, and Rhonda, who is living with chronic hepatitis B, discuss what to do when the decision to start treatment is not clear because of borderline ALT test results and HBV DNA levels.

Decera Clinical Education Infectious Disease Podcast · Anna Christina L. dela Cruz MD

July 28, 202115m 11s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In episode 5 of an ongoing series of sharing sessions between a physician and patient, Anna Christina L. dela Cruz, MD, and Rhonda, who is living with chronic hepatitis B, discuss what to do when the decision to start treatment is not clear because of borderline ALT test results and HBV DNA levels. Their conversation highlights a need for patient education and shared decision-making.

Presenter:

Anna Christina L. dela Cruz, MD
Associate Professor
Division of Digestive Diseases and Nutrition
Department of Internal Medicine
University of Kentucky
Lexington, Kentucky

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program:
https://bit.ly/3u196yK


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

hbv treatmenthepatitis b transmissionhbv tenofovir alafenamidehbv stigmahbv tafaasld guidelineshepatitis b monitoringhepatitis b treatmenthepatitis bhbv transmissionhbv tdfhbv screeninghbv tenofovir disoproxil fumaratehbv patient perspectivehepatitis shared decision makinghbvhbv monitoringhbv gray zone